Sale!

SNAI2 Gene Waardenburg Syndrome Type 2D Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SNAI2 gene plays a crucial role in the development of Waardenburg syndrome type 2D, a genetic condition characterized by varying degrees of hearing loss and pigmentation anomalies of the hair, skin, and eyes. This condition is part of a group of genetic disorders that can also affect the structure of the inner ear and lead to sensorineural hearing loss.

A genetic test specifically designed to identify mutations in the SNAI2 gene can be a critical tool for diagnosing Waardenburg syndrome type 2D. This test involves analyzing the DNA to look for specific mutations in the SNAI2 gene that are known to cause the syndrome. It is a crucial step for families seeking a definitive diagnosis, especially when planning for children or understanding the risk for future generations.

DNA Labs UAE offers this specialized genetic testing service. The test cost is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the SNAI2 gene. Conducting the test in a reputable laboratory like DNA Labs UAE ensures reliability and accuracy, providing essential information for affected individuals and their families to manage the condition effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SNAI2 Gene Waardenburg syndrome type 2D Genetic Test

Components

  • Test Name: SNAI2 Gene Waardenburg syndrome type 2D Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for SNAI2 Gene Waardenburg syndrome type 2D NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SNAI2 Gene Waardenburg syndrome type 2D

Test Details

The SNAI2 gene is associated with Waardenburg syndrome type 2D (WS2D), which is a rare genetic disorder characterized by hearing loss and pigmentation abnormalities. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to rapidly and accurately analyze multiple genes or even the entire genome. In the case of WS2D, NGS can be used to sequence the SNAI2 gene and identify any mutations or variations that may be present.

By analyzing the SNAI2 gene through NGS, healthcare professionals can determine if a person has a mutation or variation in this gene that is associated with WS2D. This information can be used for diagnostic purposes, to provide genetic counseling to affected individuals and their families, and to guide treatment decisions.

Test Name SNAI2 Gene Waardenburg syndrome type 2D Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SNAI2 Gene Waardenburg syndrome type 2D NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SNAI2 Gene Waardenburg syndrome type 2D
Test Details

The SNAI2 gene is associated with Waardenburg syndrome type 2D (WS2D), which is a rare genetic disorder characterized by hearing loss and pigmentation abnormalities.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to rapidly and accurately analyze multiple genes or even the entire genome. In the case of WS2D, NGS can be used to sequence the SNAI2 gene and identify any mutations or variations that may be present.

By analyzing the SNAI2 gene through NGS, healthcare professionals can determine if a person has a mutation or variation in this gene that is associated with WS2D. This information can be used for diagnostic purposes, to provide genetic counseling to affected individuals and their families, and to guide treatment decisions.